ASXL1 mutations are frequent, with the disease displaying a higher prevalence of ETNK1, SETBP1, and EZH2 mutations in comparison to other MDS/MPN overlap neoplasms. This evidence concerns the gene ETNK1 and myeloproliferative neoplasm.